| dc.contributor.author | Boucher, Charles A. | |
| dc.contributor.author | Tabak, Fehmi | |
| dc.contributor.author | Mach, Tomasz H. | |
| dc.contributor.author | Hansen, Bettina E. | |
| dc.contributor.author | Janssen, Harry L. | |
| dc.contributor.author | Sonneveld, Milan J. | |
| dc.contributor.author | Rijckborst, Vincent | |
| dc.contributor.author | Zoutendijk, Roeland | |
| dc.contributor.author | Gerken, Guido | |
| dc.date.accessioned | 2021-03-06T10:40:32Z | |
| dc.date.available | 2021-03-06T10:40:32Z | |
| dc.identifier.citation | Sonneveld M. J. , Rijckborst V., Zoutendijk R., Gerken G., Tabak F., Mach T. H. , Boucher C. A. , Hansen B. E. , Janssen H. L. , "HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B", 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_eb83c6b6-eef6-40ca-a1c0-748d985f4e4b | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/154670 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.title | HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B | |
| dc.type | Bildiri | |
| dc.contributor.department | Erasmus University Rotterdam , , | |
| dc.identifier.volume | 54 | |
| dc.contributor.firstauthorID | 138755 | |
